KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to -$283.0 million.

  • Merck's Cash from Investing Activities rose 9263.98% to -$283.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 billion, marking a year-over-year increase of 3612.31%. This contributed to the annual value of -$7.7 billion for FY2024, which is 4508.27% up from last year.
  • Latest data reveals that Merck reported Cash from Investing Activities of -$283.0 million as of Q3 2025, which was up 9263.98% from -$770.0 million recorded in Q2 2025.
  • Merck's Cash from Investing Activities' 5-year high stood at $53.0 million during Q4 2023, with a 5-year trough of -$12.0 billion in Q4 2021.
  • For the 5-year period, Merck's Cash from Investing Activities averaged around -$2.4 billion, with its median value being -$1.2 billion (2022).
  • In the last 5 years, Merck's Cash from Investing Activities surged by 10303.2% in 2023 and then plummeted by 282452.83% in 2024.
  • Over the past 5 years, Merck's Cash from Investing Activities (Quarter) stood at -$12.0 billion in 2021, then soared by 85.49% to -$1.7 billion in 2022, then skyrocketed by 103.03% to $53.0 million in 2023, then tumbled by 2824.53% to -$1.4 billion in 2024, then soared by 80.4% to -$283.0 million in 2025.
  • Its Cash from Investing Activities was -$283.0 million in Q3 2025, compared to -$770.0 million in Q2 2025 and -$1.5 billion in Q1 2025.